CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Eargo, Inc. - EAR CFD

4.0138
4.74%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0324
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 0.01
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.2135
Open* 4.0736
1-Year Change* -22.41%
Day's Range* 3.9938 - 4.1935
52 wk Range 4.14-116.80
Average Volume (10 days) 70.56K
Average Volume (3 months) 2.22M
Market Cap 85.81M
P/E Ratio -100.00K
Shares Outstanding 20.73M
Revenue 34.39M
EPS -80.92
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Mar 23, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 20, 2023 4.0138 -0.1497 -3.60% 4.1635 4.2035 3.9938
Mar 17, 2023 4.1736 -0.4193 -9.13% 4.5929 4.6727 4.1735
Mar 16, 2023 4.6927 0.3396 7.80% 4.3531 4.8226 4.3432
Mar 15, 2023 4.5829 0.0899 2.00% 4.4930 4.6429 4.3832
Mar 14, 2023 4.6428 -0.0598 -1.27% 4.7026 4.8425 4.6129
Mar 13, 2023 4.7726 0.0300 0.63% 4.7426 4.9124 4.5429
Mar 10, 2023 4.8226 -0.2195 -4.35% 5.0421 5.1221 4.7027
Mar 9, 2023 5.1021 -0.2496 -4.66% 5.3517 5.5215 5.0622
Mar 8, 2023 5.3317 0.0400 0.76% 5.2917 5.3917 5.0421
Mar 7, 2023 5.3717 -0.2894 -5.11% 5.6611 5.7612 5.3418
Mar 6, 2023 5.6413 -0.2696 -4.56% 5.9109 6.0108 5.5714
Mar 3, 2023 5.9109 0.2098 3.68% 5.7011 6.0907 5.6612
Mar 2, 2023 5.8410 0.0300 0.52% 5.8110 5.9609 5.6014
Mar 1, 2023 6.0008 0.0500 0.84% 5.9508 6.0607 5.6812
Feb 28, 2023 6.0207 -0.1297 -2.11% 6.1504 6.2304 5.8908
Feb 27, 2023 6.2305 -0.0997 -1.57% 6.3302 6.4801 6.1704
Feb 24, 2023 6.2404 -0.7487 -10.71% 6.9891 6.9992 6.1705
Feb 23, 2023 7.0991 -0.0898 -1.25% 7.1889 7.3288 6.7894
Feb 22, 2023 6.9893 -0.0298 -0.42% 7.0191 7.1490 6.4900
Feb 21, 2023 7.1491 -0.1396 -1.92% 7.2887 7.4187 7.1490

Eargo, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2017 2018 2019 2020 2021
Total revenue 6.62 23.163 32.79 69.154 32.122
Revenue 6.62 23.163 32.79 69.154 32.122
Cost of Revenue, Total 4.467 11.423 15.79 21.873 27.956
Gross Profit 2.153 11.74 17 47.281 4.166
Total Operating Expense 28.307 55.293 76.826 105.652 188.829
Selling/General/Admin. Expenses, Total 15.043 33.791 48.195 70.107 135.641
Research & Development 5.449 9.52 12.841 12.045 25.232
Unusual Expense (Income) 3.348 0.559 0 1.627 0
Operating Income -21.687 -32.13 -44.036 -36.498 -156.707
Interest Income (Expense), Net Non-Operating -1.748 -0.26 -0.084 -1.883 -1.047
Other, Net -1.181 -1.403 -0.366 -1.474 0
Net Income Before Taxes -24.616 -33.793 -44.486 -39.855 -157.754
Net Income After Taxes -24.616 -33.793 -44.486 -39.855 -157.754
Net Income Before Extra. Items -24.616 -33.793 -44.486 -39.855 -157.754
Net Income -24.616 -33.793 -44.486 -39.855 -157.754
Income Available to Common Excl. Extra. Items -24.616 -33.766 -44.486 -30.015 -157.754
Income Available to Common Incl. Extra. Items -24.616 -33.766 -44.486 -30.015 -157.754
Diluted Net Income -24.616 -33.766 -44.486 -30.015 -157.754
Diluted Weighted Average Shares 85.4312 85.4312 85.4312 38.2466 38.8995
Diluted EPS Excluding Extraordinary Items -0.28814 -0.39524 -0.52072 -0.78478 -4.05543
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.24895 -0.3887 -0.52072 -0.74224 -4.05543
Total Adjustments to Net Income 0.027 0 9.84 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 22.048 22.883 -22.869 10.06 9.176
Revenue 22.048 22.883 -22.869 10.06 9.176
Cost of Revenue, Total 6.297 6.462 7.552 7.645 5.491
Gross Profit 15.751 16.421 -30.421 2.415 3.685
Total Operating Expense 35.417 41.945 56.179 55.288 39.562
Selling/General/Admin. Expenses, Total 24.342 30.335 41.331 39.633 28.224
Research & Development 4.778 5.148 7.296 8.01 5.847
Operating Income -13.369 -19.062 -79.048 -45.228 -30.386
Interest Income (Expense), Net Non-Operating -0.252 -0.26 -0.267 -0.268 -0.259
Other, Net 0 0 0 0
Net Income Before Taxes -13.621 -19.322 -79.315 -45.496 -30.645
Net Income After Taxes -13.621 -19.322 -79.315 -45.496 -30.645
Net Income Before Extra. Items -13.621 -19.322 -79.315 -45.496 -30.645
Net Income -13.621 -19.322 -79.315 -45.496 -30.645
Income Available to Common Excl. Extra. Items -13.621 -19.322 -79.315 -45.496 -30.645
Income Available to Common Incl. Extra. Items -13.621 -19.322 -79.315 -45.496 -30.645
Diluted Net Income -13.621 -19.322 -79.315 -45.496 -30.645
Diluted Weighted Average Shares 38.2834 38.8069 39.1952 39.3024 39.3234
Diluted EPS Excluding Extraordinary Items -0.35579 -0.4979 -2.02359 -1.15759 -0.77931
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.35579 -0.4979 -2.02359 -1.15759 -0.77931
Unusual Expense (Income) 0 0
Total Adjustments to Net Income 0 0
  • Annual
  • Quarterly
2017 2018 2019 2020 2021
Total Current Assets 11.081 55.689 19.913 222.457 139.632
Cash and Short Term Investments 9.019 51.051 13.384 212.185 110.5
Cash & Equivalents 9.019 51.051 13.384 212.185 110.5
Total Receivables, Net 0.651 0.965 2.051 3.793 12.547
Accounts Receivable - Trade, Net 0.651 0.965 2.051 3.793 12.547
Total Inventory 0.41 2.16 2.88 2.739 5.712
Prepaid Expenses 0.851 1.363 1.598 3.74 10.873
Other Current Assets, Total 0.15 0.15 0
Total Assets 11.954 59.042 27.305 232.632 160.111
Property/Plant/Equipment, Total - Net 0.812 2.949 5.4 9.113 16.716
Property/Plant/Equipment, Total - Gross 1.691 4.16 8.119 14.2 25.614
Accumulated Depreciation, Total -0.879 -1.211 -2.719 -5.087 -8.898
Other Long Term Assets, Total 0.061 0.404 1.992 1.062 1.209
Total Current Liabilities 7.722 12.66 22.29 23.718 72.383
Accounts Payable 2.419 5.175 5.428 6.02 9.053
Accrued Expenses 2.855 5.723 9.939 14.358 9.609
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.278 0 4.8 0 3.333
Other Current Liabilities, Total 0.17 1.762 2.123 3.34 50.388
Total Liabilities 12.49 20.026 30.528 38.721 90.947
Total Long Term Debt 4.767 7.071 7.842 14.837 11.924
Long Term Debt 4.767 7.071 7.842 14.837 11.924
Other Liabilities, Total 0.001 0.295 0.396 0.166 6.64
Total Equity -0.536 39.016 -3.223 193.911 69.164
Redeemable Preferred Stock 79.129 152.015 152.88 0 0
Common Stock 0 0 0 0.004 0.004
Additional Paid-In Capital 1.259 1.718 3.1 392.965 425.972
Retained Earnings (Accumulated Deficit) -80.924 -114.717 -159.203 -199.058 -356.812
Total Liabilities & Shareholders’ Equity 11.954 59.042 27.305 232.632 160.111
Total Common Shares Outstanding 85.4312 85.4312 85.4312 38.2466 39.3071
Goodwill, Net 0.873
Intangibles, Net 1.681
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 212.601 200.823 179.568 139.632 116.8
Cash and Short Term Investments 201.624 179.354 156.442 110.5 89.232
Cash & Equivalents 201.624 179.354 156.442 110.5 89.232
Total Receivables, Net 5.339 15.361 14.96 12.547 12.253
Accounts Receivable - Trade, Net 5.339 15.361 14.96 12.547 12.253
Total Inventory 2.463 3.202 6.274 5.712 5.787
Prepaid Expenses 3.175 2.906 1.892 10.873 9.528
Total Assets 223.829 215.535 200.885 160.111 135.535
Property/Plant/Equipment, Total - Net 10.142 10.763 17.399 16.716 15.792
Property/Plant/Equipment, Total - Gross 15.964 17.274 25.029 25.614 25.417
Accumulated Depreciation, Total -5.822 -6.511 -7.63 -8.898 -9.625
Other Long Term Assets, Total 1.086 1.086 1.21 1.209 0.544
Total Current Liabilities 22.769 24.372 77.945 72.383 77.105
Accounts Payable 6.604 6.764 10.998 9.053 12.029
Accrued Expenses 11.297 14.782 10.513 9.609 9.473
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 4.868 2.826 54.767 50.388 50.603
Total Liabilities 37.972 39.626 98.308 90.947 93.969
Total Long Term Debt 14.94 15.045 13.484 11.924 10.363
Long Term Debt 14.94 15.045 13.484 11.924 10.363
Other Liabilities, Total 0.263 0.209 6.879 6.64 6.501
Total Equity 185.857 175.909 102.577 69.164 41.566
Redeemable Preferred Stock 0 0 0
Common Stock 0.004 0.004 0.004 0.004 0.004
Additional Paid-In Capital 398.532 407.906 413.889 425.972 429.019
Retained Earnings (Accumulated Deficit) -212.679 -232.001 -311.316 -356.812 -387.457
Total Liabilities & Shareholders’ Equity 223.829 215.535 200.885 160.111 135.535
Total Common Shares Outstanding 38.2981 39.1416 39.2705 39.3071 39.3445
Goodwill, Net 0.873 0.873 0.873 0.873
Intangibles, Net 1.99 1.835 1.681 1.526
Current Port. of LT Debt/Capital Leases 1.667 3.333 5
  • Annual
  • Quarterly
2017 2018 2019 2020 2021
Net income/Starting Line -24.616 -33.793 -44.486 -39.855 -157.754
Cash From Operating Activities -14.292 -27.149 -39.108 -26.041 -98.456
Cash From Operating Activities 0.371 0.695 1.528 2.525 4.202
Non-Cash Items 6.372 1.643 1.934 13.18 38.984
Cash Interest Paid 1.216 0.563 0.395 0.398 0.646
Changes in Working Capital 3.581 4.306 1.916 -1.891 16.112
Cash From Investing Activities -0.369 -2.547 -3.859 -5.079 -7.587
Capital Expenditures -0.369 -2.547 -3.859 -5.079 -4.724
Cash From Financing Activities 13.531 71.728 5.15 229.921 4.358
Financing Cash Flow Items 0 0 -0.758 -2.614 -0.04
Issuance (Retirement) of Stock, Net 11.531 72.417 0.908 220.202 4.398
Issuance (Retirement) of Debt, Net 2 -0.689 5 12.333 0
Net Change in Cash -1.13 42.032 -37.817 198.801 -101.685
Cash Taxes Paid 0.063 0.107
Other Investing Cash Flow Items, Total -2.863
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -13.621 -32.943 -112.258 -157.754 -30.645
Cash From Operating Activities -9.309 -31.406 -53.499 -98.456 -20.35
Cash From Operating Activities 0.735 1.424 2.78 4.202 1.419
Non-Cash Items 5.591 11.728 26.271 38.984 3.663
Cash Taxes Paid 0.176 -0.322 0.084 0.107
Cash Interest Paid 0.159 0.34 0.485 0.646
Changes in Working Capital -2.014 -11.615 29.708 16.112 5.213
Cash From Investing Activities -1.37 -5.398 -6.57 -7.587 -0.942
Capital Expenditures -1.37 -2.964 -4.136 -4.724 -0.942
Cash From Financing Activities 0.118 3.973 4.326 4.358 0.024
Issuance (Retirement) of Stock, Net 0.118 3.973 4.326 4.398 0.093
Issuance (Retirement) of Debt, Net 0 0 0 0
Net Change in Cash -10.561 -32.831 -55.743 -101.685 -21.268
Other Investing Cash Flow Items, Total -2.434 -2.434 -2.863
Financing Cash Flow Items 0 -0.04 -0.069
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Patient Square Capital, LP Private Equity 76.3321 15821299 0 2023-01-19 MED
The Charles and Helen Schwab Living Trust Corporation 5.2317 1084371 -1 2023-01-19 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.3954 289234 261829 2022-12-31 LOW
New Enterprise Associates (NEA) Venture Capital 1.0904 226010 -32 2022-12-31 LOW
Oasis Management Company Ltd. Investment Advisor/Hedge Fund 0.7502 155488 119918 2022-12-31 LOW
Nan Fung Group Holdings Ltd Corporation 0.7136 147905 3569 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4749 98432 86767 2022-12-31 LOW
Gilde Healthcare Partners B.V. Venture Capital 0.4509 93465 -56369 2022-10-11 LOW
Millennium Management LLC Hedge Fund 0.289 59902 51370 2022-12-31 HIGH
Renaissance Technologies LLC Hedge Fund 0.2517 52176 -486 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.1844 38217 17892 2022-12-31 LOW
GSA Capital Partners LLP Hedge Fund 0.14 29028 29028 2022-12-31 HIGH
Wu (David James) Individual Investor 0.1228 25463 0 2023-01-19 HIGH
BNY Mellon Asset Management Investment Advisor 0.0934 19356 11443 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.0605 12546 10071 2022-12-31 LOW
CSS, LLC Investment Advisor 0.0601 12454 12454 2022-12-31 HIGH
Susquehanna International Group, LLP Investment Advisor 0.0558 11567 -8239 2022-12-31 MED
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.0542 11238 0 2022-12-31 LOW
Brownie (William H) Individual Investor 0.0378 7842 -15 2023-02-17 LOW
Group One Trading, L.P. Research Firm 0.0355 7352 -391 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
500000+

Trader

92000+

Klien aktif per bulan

$53000000+

Volume investasi per bulan

$30000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Advanced Medical Equipment & Technology (NEC)

2665 North First Street
Suite 300
SAN JOSE
CALIFORNIA 95134
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

27,635.85 Price
-1.770% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

XRP/USD

0.39 Price
+2.420% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00393

Gold

1,970.54 Price
-0.290% 1D Chg, %
Biaya inap posisi Long -0.0172%
Biaya inap posisi short 0.0089%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

US100

12,592.90 Price
+0.230% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda